Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation

EuroIntervention

13 November Nov 2018 27 days ago
  • Bartorelli A

Aim of the paper is to investigate the predictors of long-term adverse clinical events after implantation of the everolimus-eluting Absorb bioresorbable vascular scaffold (BVS).

Optimal Absorb BVS implantation and the use of intravascular imaging guidance were associated to lower rates of adverse events at long-term follow-up.


Reference
1. Caixeta A, Campos CM, Felix C, Chieffo A, Capranzano P, Kawamoto H, Tamburino C, Diletti R, de Ribamar Costa J Jr, Onuma Y, van Geuns RJ, Bartorelli AL, Colombo A, Tamburino C, Serruys PW, Abizaid A. Predictors of Long-term Adverse Events After Absorb Bioresorbable Vascular Scaffold Implantation: A 1,933-Patient Pooled Analysis From International Registries. EuroIntervention 2018 Oct 30. pii: EIJ-D-16-00796. doi: 10.4244/EIJ-D-16-00796. [Epub ahead of print] Go to PubMed